Agronomics plc (LON:ANIC), a leading listed investor in alternative proteins with a focus on cellular agriculture and cultivated meat, has announced that two of its portfolio companies BlueNalu, Inc. and CellX Limited have
Agronomics plc (LON:ANIC) has provided its half year newsletter in the attached link: https://mailchi.mp/23b24b9ccab1/wlydxm162w-4173621 About Agronomics Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and
Agronomics plc (LON:ANIC), the leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat, has announced the disposal of its total holding of 23,147 shares in
Agronomics plc (LON:ANIC), the leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat, has announced portfolio company CellX Limited has completed its Seed financing round. Agronomics invested
Agronomics plc (LON:ANIC), the leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat, has announced portfolio company LIVEKINDLY Collective has closed a US$ 335 million
Agronomics plc (LON:ANIC), a leading listed investor in alternative proteins with a focus on cellular agriculture and cultivated meat, has announced that portfolio company LIVEKINDLY Collective has appointed 6 new
Agronomics plc (LON:ANIC), the leading London-listed investor in alternative proteins with a focus on cellular agriculture and cultivated meat, has announced it has today invested a further US$ 500,000 in
Agronomics Limited (LON:ANIC), a leading listed investor in alternative proteins with a focus on cellular agriculture and cultivated meat, has announced its unaudited interim results for the six-month period ending
Agronomics plc (LON:ANIC), a leading listed investor in alternative proteins with a focus on cellular agriculture and cultivated meat, has announced that the Company has completed a subscription of US$ 50,000,
Agronomics plc (LON:ANIC) has announced that portfolio company Solar Foods Oy, focussed on developing its novel protein Solein, has received €4.3 million of new funding to support its €8.6 million
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
